ITOC – 3rd Immunotherapy of Cancer Conference

21st to 23rd March 2016, Munich, Germany.



ITOC (Immunotherapy of Cancer Conference) is the European meeting intended to provide a platform for preclinical and clinical researchers in the field of immunotherapy.

The conference will offer a wide range of opportunities and tools to gain exposure to experts in various disciplines within Europe and far beyond, or present your organisation’s data and advancements in this area. The support and partnership from industry, companies and foundations is invaluable to the success of ITOC conferences, helping to push further the opportunities that will ultimately aid in revolutionising the way cancer is treated.

The Invitation to Industry (ITI) makes available a wide range of exciting marketing and promotional support items at the Conference to help raise your profile amongst this target audience.

As always, the Exhibition forms an integral part of the Conference, ensuring that industry partners will have the opportunity to directly interact with delegates seeking new approaches and solutions to aid them in their daily practice.

Conference Objectives


  • To bring together preclinical and clinical scientists, academia

and clinical investigators to address unique challenges of immunotherapy

  • To provide opportunities to present scientific data in relation to early

clinical trials

  • To encourage new approaches for translation research and biomarkers
  • To translate molecular targets into effective cancer therapy
  • To bring together a multi-stakeholder audience and foster productive collaboration


General information

Date: 21st to 23rd March 2016

Munich Tumour Centre
Ismaninger Straße 22
81675 Munich

Program: Find the official program here.


Tip: More up to date educational events can be found online in the Education Database »medicine & health«.





    Comments are closed.